Erythrodermic Psoriasis
Stories
-
Takeda posts results of Phase 3 TAK-279 study in psoriasis
The study enrolled 18 participants and completed primary data collection on October 17, 2025. Results were first posted on ClinicalTrials.gov on November 4, 2026.